Description

Letrozol Coated Tablets 2.5 mg. №30

Ingredients

Each coated tablet contains 2.5 mg of Letrozole as the active ingredient.

Dosage

The recommended dosage of Letrozol is one 2.5 mg coated tablet once daily, with or without food.

Indications

Letrozol is indicated for the treatment of hormone receptor-positive early breast cancer in postmenopausal women.

Contraindications

Do not use Letrozol if you are pregnant, breastfeeding, or allergic to any of the ingredients in the product.

Directions

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Scientific Evidence

Letrozole, the active ingredient in Letrozol tablets, is an aromatase inhibitor that works by reducing the production of estrogen in the body. This mechanism of action has been shown to be effective in the treatment of hormone receptor-positive breast cancer. Clinical studies have demonstrated the efficacy of Letrozole in improving disease-free survival and reducing the risk of cancer recurrence compared to tamoxifen.

Additional Information

It is important to follow the prescribed dosage and duration of treatment with Letrozol to achieve the best results. Common side effects may include hot flashes, fatigue, and joint pain. If you experience any severe or persistent side effects, consult your healthcare provider immediately.

Before starting Letrozol treatment, inform your doctor about any other medications you are taking, as drug interactions may occur. Regular monitoring and follow-up appointments are essential during the course of treatment to assess the response to therapy and manage any potential side effects.